| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 85,970 | 73,383 | 84,578 | 65,146 | | Cost of Revenue | 60,166 | 55,746 | 63,509 | 51,870 | | | Gross Profit | 25,804 | 17,637 | 21,069 | 13,276 | | | Operating Expenses | | Research Development | 1,784 | 1,331 | 1,346 | 1,619 | | Selling General and Administrative | 12,859 | 12,773 | 12,186 | 12,106 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,161 | 3,533 | 7,537 | (449) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 228 | 243 | 836 | 463 | | Earnings Before Interest And Taxes | 11,389 | 3,776 | 8,373 | 14 | | Interest Expense | 461 | 460 | 465 | 480 | | Income Before Tax | 10,928 | 3,316 | 7,908 | (466) | | Income Tax Expense | 4,251 | 1,234 | 2,639 | (616) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,677 | 2,082 | 5,269 | 150 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,677 | 2,082 | 5,269 | 150 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,677 | $2,082 | $5,269 | $150 |
|
1.52% Nasdaq 0.00%
Income Statement
